HoenBDuvalX. Infective endocarditis. N Engl J Med2013; 369: 785–785.
2.
Bin AbdulhakAABaddourLMErwinPJ, et al.Global and regional burden of infective endocarditis, 1990-2010: A systematic review of the literature. Glob Heart2014; 9: 131–143.
3.
KuijpersJMKoolbergenDRGroeninkM, et al.Incidence, risk factors, and predictors of infective endocarditis in adult congenital heart disease: Focus on the use of prosthetic material. Eur Heart J2017; 38: 2048–2056.
4.
Treatment of acute rheumatic fever in children a co-operative clinical trial of A.C.T.H., cortisone, and aspirin. A joint report by the Rheumatic Fever Working Party of the Medical Research Council of Great Britain and the Subcommittee of Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association. Br Med J1955; 1: 555–574.
5.
LeportCHorstkotteDBurckhardtD. Antibiotic prophylaxis for infective endocarditis from an international group of experts towards a European consensus. Group of Experts of the International Society for Chemotherapy. Eur Heart J1995; 16(Suppl. B): 126–131.
6.
WilsonWTaubertKAGewitzM, et al.American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee; American Heart Association Council on Cardiovascular Disease in the Young; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Cardiovascular Surgery and Anesthesia; Quality of Care and Outcomes Research Interdisciplinary Working Group. Prevention of infective endocarditis: Guidelines from the American Heart Association: A guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation2007; 116: 1736–1754.
7.
HabibGHoenBTornosP, et al.ESC Committee for Practice Guidelines. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J2009; 30: 2369–2413.
8.
HabibGLancellottiPAntunesMJ, et al.ESC Scientific Document Group. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J2015; 36: 3075–3128.
9.
RicheyRWrayDStokesT. Guideline Development Group. Prophylaxis against infective endocarditis: Summary of NICE guidance. BMJ2008; 336: 770–771.
10.
ThornhillMHGibsonTBCutlerE, et al.Antibiotic prophylaxis and incidence of endocarditis before and after the 2007 AHA recommendations. J Am Coll Cardiol2018; 72: 2443–2454.
11.
ØstergaardLValeurNIhlemannN, et al.Incidence of infective endocarditis among patients considered at high risk. Eur Heart J2018; 39: 623–629.
12.
Zegri-ReirizIde AlarcónAMuñozP, et al.Spanish Collaboration on Endocarditis—Grupo de Apoyo al Manejo de la Endocarditis infecciosa en España (GAMES). Infective endocarditis in patients with bicuspid aortic valve or mitral valve prolapse. J Am Coll Cardiol2018; 71: 2731–2740.
13.
CottiEArricaMDi LenardaA, et al.The perioperative dental screening and management of patients undergoing cardiothoracic, vascular surgery and other cardiovascular invasive procedures: A systematic review. Eur J Prev Cardiol2017; 24: 409–425.
14.
ManginoMRoedererMBeddallMH, et al.Innate and adaptive immune traits are differentially affected by genetic and environmental factors. Nat Commun2017; 8: 13850–13850.
15.
MoreauKClemenceauALe MoingV, et al.French VIRSTA-AEPEI; COFRASA Study Groups; Danish DANSAB Study Group. Human genetic susceptibility to native valve Staphylococcus aureus endocarditis in patients with S. aureus bacteremia: Genome-wide association study. Front Microbiol2018; 4(9): 640–640.
16.
HoenBDuvalX. Epidemiology of infective endocarditis. Rev Prat2012; 62: 511–514.
17.
ThaissCAZmoraNLevyM, et al.The microbiome and innate immunity. Nature2016; 535: 65–74.
18.
ZencirCAkpekMSenolS, et al.Association between hematologic parameters and in-hospital mortality in patients with infective endocarditis. Kaohsiung J Med Sci2015; 31: 632–638.
19.
DayerMJJonesSPrendergastB, et al.Incidence of infective endocarditis in England, 2000–13: A secular trend, interrupted time-series analysis. Lancet2015; 385: 1219–1228.
20.
VerheugtCLUiterwaalCSVaartjesI, et al.Chance of surgery in adult congenital heart disease. Eur J Prev Cardiol2017; 24: 1319–1327.
21.
SunYPO’GaraPT. Cardiovascular conditions predisposing to infective endocarditis: Time to reconsider the current risk classification system?Eur Heart J2018; 39: 596–598.
